window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Infectious Diseases

  • Biomanufacturing,CDMOs & Manufacturing,Infectious Diseases,Partnerships & Funding,Vaccines

    Evotec unit secures BARDA deal to optimise Ebola antibody manufacturing

    Just – Evotec Biologics has been selected by BARDA to [...]

    March 23, 2026
  • Clinical Development,Clinical Trials,Drug Development,FDA,Infectious Diseases

    PolyPid prepares D-PLEX100 NDA following Phase 3 surgical infection data

    PolyPid is preparing to submit a New Drug Application for [...]

    March 18, 2026
  • Clinical Trials,Infectious Diseases,Vaccines

    Ethris part of EU consortium to advance novel pandemic influenza vaccine

    Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

    February 27, 2026
  • Clinical Development,Infectious Diseases,Patient Centricity,Precision medicine

    ViiV Healthcare reports 12-month data showing lotivibart maintains viral suppression in ultra long-acting HIV regimen

    ViiV Healthcare, the global specialist HIV company majority owned by [...]

    February 27, 2026
  • Clinical Trials,Infectious Diseases,Pharmaceuticals and therapeutics,Research & Development

    ViiV Healthcare highlights ultra long-acting HIV pipeline and Phase 1 data at CROI 2026

    ViiV Healthcare will present new data from its long-acting and [...]

    February 18, 2026
  • Infectious Diseases,Research & Development,RNA Therapeutics

    Circio and University of Texas Medical Branch partner on infectious disease research using circular RNA

    Circio has entered a research collaboration with the University of [...]

    February 9, 2026
  • Biotech,Clinical Development,Clinical Trials,Infectious Diseases,Vaccines

    NeoVac reports Phase 1 and Phase 2 data for NeomiVac mRNA LNP covid-19 vaccine

    NeoVac has reported positive first-in-human Phase 1 and Phase 2 [...]

    February 6, 2026
  • Infectious Diseases,Market Access & Commercialization,Medical devices

    Biocomposites launches SYNICEM spacers in Canada for joint revision surgery

    Biocomposites has launched its SYNICEM antibiotic-loaded preformed spacers in Canada, [...]

    January 30, 2026
  • Diagnostics,Infectious Diseases,Medical devices,Technology and platforms

    En Carta Diagnostics receives FDA breakthrough device designation for Lyme disease test

    En Carta Diagnostics has received FDA Breakthrough Device Designation for [...]

    January 30, 2026
  • Clinical Trials,Infectious Diseases,Research & Development

    Cytespace Africa Labs expands molecular testing capacity to support clinical trials across sub-Saharan Africa

    Cytespace Africa Laboratories has expanded its molecular testing capacity to [...]

    January 21, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Healthcare leadership, Mergers & Acquisitions, Movers & Shakers, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Healthcare leadership, Market Access & Commercialization, Movers & Shakers, Pharmaceuticals and therapeutics, Startups and innovations
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Oncology, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top